Yanhuai (Richard) DingSr . Director, CMC DS/DP at EvolveImmune Therapeutics Inc.Speaker
Profile
Dr. Yanhuai (Richard) Ding: Sr. Director, CMC DS/DP, EvolveImmune Therapeutics, Inc.; Previously worked in ThermoFisher, Shire HGT, Lonza, AnaptysBio, Biogen, Immunogen; Earned his Ph.D. in biochemistry and molecular biology from The University of Waikato, New Zealand; With more than 25 years of experience in CMC, fermentation/cell culture, protein purification, technology transfer, manufacturing troubleshooting, VC, PC, PV, clinical-in-use, and IND/IMPD filing; Developed bsAbs, mAbs, Fabs, enzymes, HIV vaccine, Collagen 7, biosimilars, plasmids and AAV; Published 37 articles (USA, New Zealand, and China), two book chapters, one in Bioprocessing, Bioengineering and Process Chemistry in the Biopharmaceutical Industry (Springer Nature 2024, edited by Dr. K Gadamasetti & SA Kolodziej) and the other in Process Scale Purification of Antibodies (Wiley, 3rd edition by Dr. U Gottschalk 2026); filed a patent for cancer therapy by tsAb and invent novel purification process and manufacturing for HIV vaccine and AAV development…
Agenda Sessions
CMC strategies for novel tri-specific antibody process development and manufacturing for solid tumor therapy
, 09:35View Session
